Several of the world's largest pharmaceutical companies and the Food and Drug Administration are setting up the nonprofit Serious Adverse Event Consortium to study why some people are predisposed to
dangerous drug interactions and serious illness when taking new prescriptions.
Founders of the organization include Abbott Laboratories, Johnson & Johnson and Pfizer. Its office will
be based in Deerfield, Il.
Drug companies, which have large databases of reports from patients and doctors on how their drugs interact with patients, say they will use information to
conduct studies to map "genetic markers" linked to serious adverse events. But because new medications are complicated and costly to develop, these companies and their academic partners cannot tackle
the issue on their own.
advertisement
advertisement
Read the whole story at Chicago Tribune »